North America Epigenetics Market

North America Epigenetics Market Size

296.93 MnRising cancer prevalence, and increased research and development activities, and growing applications in Epigenetics are majorly promoting the growth rate of the North American epigenetics market. Also, the financing for epigenetics research and developing uses of epigenetics in non-oncology illnesses contribute to the market growth. Moreover, Cancer is the second most common cause of mortality in the United States, accounting for almost one out of every four fatalities.

In the coming years, the expanding application areas of epigenetics in non-oncology illnesses, customized medicine, and target treatment are likely to create potential possibilities for market participants. Also, increase in the risk of cardiovascular diseases and an increase in the investments in research and development practices.

The market expansion is hampered by the high cost of instruments, a scarcity of skilled specialists. Also, the scarcity and lack of financing plans and awareness about epigenetics impede market growth.

MARKET SEGMENTATION

This research report on the North America Epigenetics Market has been segmented & sub-segmented into the following categories

North America Epigenetics Market - By Product

• Enzymes

• Instruments & Consumable

• KITS
• Reagents

North America Epigenetics Market - By Research Area

• Developmental Biology

• Oncology

• Drug Delivery

North America Epigenetics Market - By Enzymes

• DNA-Modifying Enzymes

• Protein-Modifying Enzymes

• RNA-Modifying Enzymes

North America Epigenetics Market - By Instruments & Consumables

• Mass Spectrometers

• Next-Generation Sequencers

• qPCR
• Sonicators

North America Epigenetics Market - By KITS

• Bisulfite Conversion KITS

• Chip-Sequence KITS

• RNA Sequencing KITS
• Whole-Genome Amplification KITS
• 5-HMC and 5-MC Analysis KITS

North America Epigenetics Market - By Reagents

• Antibodies

• Buffers

• Histones
• Magnetic Beads
• Primers

North America Epigenetics Market - By Country

• The U.S.

• Canada

• Rest of North America

Geographically, North America dominated the global market in 2023 due to its advanced technology and significant presence.

The U.S. Epigenetics Market is estimated to account for the most significant share in the North American epigenetics market during the forecast period. Y-O-Y growth in cancer incidence is majorly accelerating the epigenetics market in the United States. In addition, enlarging epigenetics applications in non-oncology diseases, personalized medicine, and target therapy are further anticipated to boost the market's growth rate.

The Canadian epigenetics market is predicted to be another lucrative regional market in the North American market during the forecast period. The increasing obesity population, growing research on oncology diseases, and increasing collaborations between research institutes, biotechnology, and biopharmaceutical companies are estimated to support Canada's market growth.

KEY MARKET PLAYERS

A few of the notable companies playing a leading role in the North America epigenetics market are Abcam plc., Illumina, Inc., QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Active Motif, Diagenode, Inc., and Zymo Research Corporation.